Direct to Biology for Drug Discovery Acceleration: Syngene’s D2B Platform

Latest Blogs

Semi-targeted integration in cell line development supports stable clone selection and more predictable biologics development.

What semi-targeted integration changes in biologics development

India as a Global CRDMO Powerhouse: Debunking Quality Myths

Oligonucleotide Analytical Development: Five Hidden Traps and How to Avoid Them

Allometric scaling vs PBPK: when each approach helps in human dose prediction

From PBPK modeling to first-in-human dose: how predictive DMPK can reduce early clinical risk

Infographic showing how pharmacokinetic variability, food effect, dose burden and swallowability affect bioavailability and patient adherence in oral solid dosage forms.

Engineering Oral Solid Dosage Forms to Enhance Therapeutic Efficiency & Patient Acceptability